All Stories

  1. A Dene First Nation’s community readiness assessment to take action against HIV/AIDS: a pilot project
  2. Dolutegravir with boosted darunavir treatment simplification for the transmitted HIV thymidine analog resistance in Manitoba, Canada
  3. Characteristics of hospital admissions for pneumonia in HIV-positive individuals in Winnipeg, Manitoba: a cross-sectional retrospective analysis
  4. Systemic inflammation before and after antiretroviral therapy initiation as a predictor of immune response among HIV-infected individuals in Manitoba
  5. Immune Reconstitution Syndrome secondary to Rhodococcus equi infection in a patient with HIV and Burkitt's lymphoma
  6. Lymphadenopathy
  7. Evaluation and Management of the Solitary Enlarged Lymph Node
  8. Evaluation of the Utility of Point-of-Care HIV Testing on a Canadian Internal Medicine Inpatient Unit
  9. Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis
  10. A case of tetanus secondary to an odontogenic infection
  11. Alternative Cardiac Imaging Modalities to Echocardiography for the Diagnosis of Infective Endocarditis
  12. Inflammatory cytokine and gene expression patterns correlate with etiologic agent causing pneumonia among patients with advanced HIV in Medellin, Colombia
  13. Prior history of testing for syphilis, hepatitis B and hepatitis C among a population-based cohort of HIV-positive individuals and their HIV-negative controls
  14. Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults
  15. Utilization of Echocardiography in Patients With Staphylococcus aureus Bacteremia at Two Large Canadian Hospitals
  16. Quintessential Culture-Negative Endocarditis
  17. Blood Culture Negative Endocarditis
  18. Changing Populations: The Elderly, Injection Drug Users, Health-Care Associated Endocarditis and Immunocompromised Patients
  19. Group C and G Streptococci: An Emerging Cause of Endocarditis and Severe Infections in Manitoba, Canada
  20. Unique cytokine and chemokine patterns in bronchoalveolar lavage are associated with specific causative pathogen among HIV infected patients with pneumonia, in Medellin, Colombia
  21. Substance use and its impact on care outcomes among HIV-infected individuals in Manitoba
  22. Rapid human immunodeficiency virus disease progression is associated with human leukocyte antigen-B homozygocity and human leukocyte antigen-B51 in a cohort from Manitoba, Canada
  23. Relapse of Visceral Leishmaniasis in an HIV-Infected Patient Successfully Treated with a Combination of Miltefosine and Amphotericin B
  24. Changing trends in β-hemolytic streptococcal bacteremia in Manitoba, Canada: 2007–2012
  25. Vancomycin Revisited – 60 Years Later
  26. Hypermucoviscous Klebsiella Syndrome Without Liver Abscess in a Patient With Immunoglobulin G2 Immune Deficiency
  27. Letter to the Editor
  28. Vancomycin-Resistant Enterococci
  29. Infective Endocarditis in the Intensive Care Unit
  30. Quinolones for mycobacterial infections
  31. Staphylococcus aureus Bacteremia, Risk Factors, Complications, and Management
  32. Pathophysiology of Infective Endocarditis
  33. Short-course therapy for severe infections
  34. Diarrhea and Colonic Ulcers of Unusual Etiology
  35. Feasibility and Success of Hiv Point-of-Care Testing in an Emergency Department in an Urban Canadian Setting
  36. Legionella pneumophilaSerotype 1 Pneumonia in Patient Receiving Adalimumab
  37. Invariant NKT Cells: Regulation and Function during Viral Infection
  38. HIV Controllers Are Distinguished by Chemokine Expression Profile and HIV-Specific T-Cell Proliferative Potential
  39. Predictors of Serological Cure After Treatment of Early Syphilis
  40. Altered dendritic cell–natural killer interaction in Kenyan sex workers resistant to HIV-1 infection
  41. Genetic Polymorphisms and Drug Susceptibility in Four Isolates of Leishmania tropica Obtained from Canadian Soldiers Returning from Afghanistan
  42. Maraviroc Induced CCR5 Blockage for HIV Infected Individuals is Associated with Increased Rates of Respiratory Tract Infections
  43. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals
  44. Immunogenetic Factors Associated with Severe Respiratory Illness Caused by Zoonotic H1N1 and H5N1 Influenza Viruses
  45. Serological Survey of the Novel Influenza A H1N1 in Inner City Winnipeg, Manitoba, 2009
  46. Multiloculated Liver Abscess
  47. Targeting the Chemokine Receptor CCR5: Good for HIV, What about Other Viruses?
  48. Evaluation of Influenza-Specific Humoral Response by Microbead Array Analysis
  49. Toll-Like Receptors Dysregulation after Influenza Virus Infection: Insights into Pathogenesis of Subsequent Bacterial Pneumonia
  50. Chemokine Receptor 5 Δ32 Allele in Patients with Severe Pandemic (H1N1) 2009
  51. Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross reactivity to other strains.
  52. Are drug clinical trials broadly applicable? The case of staphylococcal bacteraemia
  53. Endogenous endophthalmitis caused by hypermucoviscous Klebsiella pneumoniae: An emerging disease in Southeast Asia and Beyond
  54. The Role of Regulatory T Cells in Chronic and Acute Viral Infections
  55. Use of Oral Miltefosine for Cutaneous Leishmaniasis in Canadian Soldiers Returning from Afghanistan
  56. The changing face of Klebsiella pneumoniae infections in the community
  57. Fungal endocarditis
  58. Hyperbaric oxygen in the treatment of sudden deafness
  59. Pulmonary Nocardia nova infection
  60. Pyogenic liver abscess caused by hypermucoviscous Klebsiella pneumoniae
  61. RESPIRATORY MUSCLE TRAINING IN OXYGEN DIVERS: REDUCED DYSPNEA AND INCREASED ENDURANCE
  62. Identification of Two Novel HLA-C Alleles, Cw*070105 and Cw*1408, from East African Women
  63. Hyperbaric therapy for bilateral visual loss during hemodialysis
  64. Hypoxia–reoxygenation contributes to increased frequency of venous thromboembolism in air travellers
  65. Hyperbaric Oxygen in the Treatment of Carbon Monoxide Poisoning
  66. Underwater Hearing and Sound Localization with and without an Air Interface
  67. Hyperbaric Oxygen in the Treatment of Carbon Monoxide Poisoning
  68. Swimming-Induced Pulmonary Edema
  69. The Impact of Solvent Use Amongst HIV + Individuals in Manitoba